Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Insulin Glargine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 86,038Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 6SANOFI-AVENTIS CANADA INC

    02 1BIOCON SDN.BHD

    03 2ELI LILLY CANADA INC

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    SANOFI-AVENTIS CANADA INC

    France
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    INSULIN GLARGINE

    Brand Name : LANTUS

    Dosage Form : SOLUTION

    Dosage Strength : 100UNIT/ML

    Packaging : 3ML

    Approval Date :

    Application Number : 2251930

    Regulatory Info : Schedule D

    Registration Country : Canada

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    SANOFI-AVENTIS CANADA INC

    France
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    INSULIN GLARGINE

    Brand Name : LANTUS

    Dosage Form : SOLUTION

    Dosage Strength : 100UNIT/ML

    Packaging : 10ML

    Approval Date :

    Application Number : 2245689

    Regulatory Info : Schedule D

    Registration Country : Canada

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    SANOFI-AVENTIS CANADA INC

    France
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    INSULIN GLARGINE

    Brand Name : LANTUS

    Dosage Form : SOLUTION

    Dosage Strength : 100UNIT/ML

    Packaging : 5X3ML

    Approval Date :

    Application Number : 2294338

    Regulatory Info : Schedule D

    Registration Country : Canada

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    SANOFI-AVENTIS CANADA INC

    France
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    INSULIN GLARGINE

    Brand Name : TOUJEO DOUBLESTAR

    Dosage Form : SOLUTION

    Dosage Strength : 300UNIT/ML

    Packaging :

    Approval Date :

    Application Number : 2493373

    Regulatory Info : Schedule D

    Registration Country : Canada

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    SANOFI-AVENTIS CANADA INC

    France
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    INSULIN GLARGINE

    Brand Name : SOLIQUA

    Dosage Form : SOLUTION

    Dosage Strength : 100UNIT/ML

    Packaging :

    Approval Date :

    Application Number : 2478293

    Regulatory Info : Prescription

    Registration Country : Canada

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    SANOFI-AVENTIS CANADA INC

    France
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    INSULIN GLARGINE

    Brand Name : TOUJEO SOLOSTAR

    Dosage Form : SOLUTION

    Dosage Strength : 300UNIT/ML

    Packaging : 3X1.5ML/ 5X1.5ML

    Approval Date :

    Application Number : 2441829

    Regulatory Info : Schedule D

    Registration Country : Canada

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    BIOCON SDN.BHD

    India
    2024 ACI Convention
    Not Confirmed
    arrow

    BIOCON SDN.BHD

    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    INSULIN GLARGINE

    Brand Name : SEMGLEE

    Dosage Form : SOLUTION

    Dosage Strength : 100UNIT/ML

    Packaging :

    Approval Date :

    Application Number : 2526441

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    ELI LILLY CANADA INC

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    ELI LILLY CANADA INC

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    INSULIN GLARGINE

    Brand Name : BASAGLAR

    Dosage Form : SOLUTION

    Dosage Strength : 100UNIT/ML

    Packaging : 3ML

    Approval Date :

    Application Number : 2461528

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    ELI LILLY CANADA INC

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    ELI LILLY CANADA INC

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    INSULIN GLARGINE

    Brand Name : BASAGLAR

    Dosage Form : SOLUTION

    Dosage Strength : 100UNIT/ML

    Packaging :

    Approval Date :

    Application Number : 2444844

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF